Pharmabiz

Roche launches VENTANA BAP1 (SP527) test for differential diagnosis of mesothelioma

Roche launches VENTANA BAP1 (SP527) test for differential diagnosis of mesothelioma: Basel Thursday, October 29, 2026, 10:00 Hrs [IST] Roche announced the global launch of the VEN ...
Pharmabiz

Astellas Pharma and Audax enter exclusive option and license agreement for DAX-044, a novel immune-targeted IL-12 antibody-cytokine fusion for immuno-oncology

Astellas Pharma and Audax enter exclusive option and license agreement for DAX-044, a novel immune-targeted IL-12 antibody-cytokine fusion for immuno-oncology: Tokyo, Japan Thursd ...
Pharmabiz

AICDF lauds govt's decision to initiate state-wise enrolment of drug licensees under NHPR

AICDF lauds govt's decision to initiate state-wise enrolment of drug licensees under NHPR: Peethaambaran Kunnathoor, Chennai Thursday, October 29, 2026, 08:00 Hrs [IST] The Kolkat ...
Pharmabiz

Karnataka govt appoints NHM CAO Venkataraju as Returning Officer for KSPC election

Karnataka govt appoints NHM CAO Venkataraju as Returning Officer for KSPC election: Nandita Vijayasimha, Bengaluru Thursday, October 29, 2026, 08:00 Hrs [IST] The Karnataka govern ...
Pharmabiz

Indian pharmacists strengthening clinical training & overall competency for career break into GCC countries

Indian pharmacists strengthening clinical training & overall competency for career break into GCC countries: Nandita Vijayasimha, Bengaluru Thursday, October 29, 2026, 08:00 Hrs [ ...
Opinion
PharmabizOpinion

TMR on non-scheduled anti-cancer formulations list points to several flaws: Experts

TMR on non-scheduled anti-cancer formulations list points to several flaws: Experts: Gireesh Babu, New Delhi Thursday, October 29, 2026, 08:00 Hrs [IST] While the National Pharmac ...
Pharmabiz

DGFT scraps UIN requirement, streamlines export factoring support for pharma MSMEs under EPM

DGFT scraps UIN requirement, streamlines export factoring support for pharma MSMEs under EPM: Shardul Nautiyal, Mumbai Thursday, October 29, 2026, 08:00 Hrs [IST] The Directorate ...
Pharmabiz

DFE Pharma appoints Peter Rose as new chief operating officer

DFE Pharma appoints Peter Rose as new chief operating officer: Goch, Germany Wednesday, October 28, 2026, 17:00 Hrs [IST] DFE ...
Pharmabiz

CSOs and patient groups welcomes IPO's rejection of patent for multi-drug resistant regimen BPaL

CSOs and patient groups welcomes IPO's rejection of patent for multi-drug resistant regimen BPaL: Our Bureau, New Delhi Wednesday, October 28, 2026, 14:10 Hrs [IST] Patient groups ...
Pharmabiz

India’s genetic diversity could make it a global destination for gene research: Dr. Jitendra Singh

India’s genetic diversity could make it a global destination for gene research: Dr. Jitendra Singh: Our Bureau, Mumbai Wednesday, October 28, 2026, 16:10 Hrs [IST] Union ministe ...
Pharmabiz

OPKO Biologics doses first participant in phase 1/2a trial of OPK-8801001 for treatment of acromegaly

OPKO Biologics doses first participant in phase 1/2a trial of OPK-8801001 for treatment of acromegaly: Kiryat Gat, Israel Wednesday, October 28, 2026, 18:00 Hrs [IST] OPKO Biologi ...
Pharmabiz

China NMPA grants marketing authorization to Bayer’s asundexian, a selective, once-daily oral Factor XIa inhibitor to reduce risk of stroke

China NMPA grants marketing authorization to Bayer’s asundexian, a selective, once-daily oral Factor XIa inhibitor to reduce risk of stroke: Berlin Wednesday, October 28, 2026, ...